Company news

Lithos Group Ltd (CSE:LITS) news

Lithos Group Ltd news releases on 6ix. Latest, Sep 29, 2026: Lite Strategy Reports Fiscal Year 2026 Financial Results

View Lithos Group Ltd →

Press releases & updates

Lite Strategy Reports Fiscal Year 2026 Financial Results

September 29, 2026

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

September 10, 2026

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

July 30, 2026

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

June 19, 2026

Lite Strategy Leads Strategic Investment in LitVM

June 18, 2026

Lite Strategy Reports Fiscal 2026 Third Quarter Results

May 13, 2026

Lite Strategy Reports Fiscal 2026 Second Quarter Results

February 17, 2026

LiTHOS Announces Board and Management Change

January 14, 2026

Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

November 17, 2025

Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations

October 29, 2025

Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026

October 16, 2025

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker 'LITS'

September 10, 2025

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

August 5, 2025

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

July 22, 2025

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

July 18, 2025

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

May 13, 2025

LiTHOS Provides Q3 Corporate & Operational Update

September 23, 2024

LiTHOS Announces Grant of RSUs and PSUs to Conserve Capital and Align Interests with Long-Term Growth

September 19, 2024

LiTHOS Announces Executive Team Expansion to Accelerate Growth in the Sustainable Lithium Sector and Financing Closure

May 29, 2024

LiTHOS Strengthens Executive Team with Strategic Promotions and Key Hires

March 27, 2024

LiTHOS CLOSES NON-BROKERED PRIVATE PLACEMENT

November 6, 2023

LiTHOS' ANNOUNCES INCREASED SIZE OF NON-BROKERED PRIVATE PLACEMENT

October 23, 2023

LiTHOS' WHOLLY OWNED SUBSIDIARY AQUEOUS RECEIVED DEFINITIVE US$1.3 MILLION FUNDING AWARD FROM THE DOE AND COMMENCES FOLLOW-ON DOE APPLICATION FOR UP TO US$30 MILLION TO FUND CRIMSON TIDE LITHIUM HYDRIOXIDE FACILITY

September 13, 2023

LiTHOS TECHNOLOGY LLC SIGNS TERM SHEET WITH SAND SPIRIT LLC TO SCOPE AND CONSTRUCT 'CRIMSON TIDE' LITHIUM HYDROXIDE PILOT PRODUCTION FACILITY IN ALABAMA

September 6, 2023

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm

May 19, 2022

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm

May 18, 2022

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 9, 2020

MEIP Final Deadline Notice: Rosen, A Longstanding And Top Ranked Law Firm, Reminds MEI Pharma, Inc. Investors of Important Friday Deadline in Securities Class Action - MEIP

October 8, 2020

DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 8, 2020

FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 7, 2020

FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 6, 2020

FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 5, 2020

ROSEN, A TRUSTED AND TOP RANKED LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP

October 2, 2020

7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 2, 2020

MEI Pharma Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MEI Pharma, Inc. To Contact The Firm

September 25, 2020

Rosen, A Trusted and Leading Law Firm, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP

September 23, 2020

Rosen, Trusted Global Investor Counsel, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP

September 18, 2020

ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MEIP

September 12, 2020

Rosen, Leading Trial Attorneys, Announces Filing of Securities Class Action Lawsuit Against MEI Pharma, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - MEIP

September 3, 2020

MEIP INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds MEI Pharma, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

August 19, 2020

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MEI Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

August 11, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MEI Pharma, Inc. - MEIP

July 1, 2020

Stock Alerts on Market Movers: GSX, IAO NPWS, SNS and NVGN from PennyStockChaser.com

July 8, 2009